Companies /Healthcare

Cogent Biosciences Inc

NASDAQ: COGT Biotechnology
$33.41
▼ $0.67 (−1.97%) today
Markets open · 4:17pm ET
Today · % change

Fundamentals

Market Cap
$5.9B
EPS (TTM)
$-2.16
52-Week Range
$12 – $44
Street Target
$55.82

About Cogent Biosciences

Cogent Biosciences Inc, based in Waltham, Massachusetts, is a pioneering biotechnology firm dedicated to creating targeted treatments for genetic diseases. Its flagship product, bezuclastinib, is a cutting-edge therapy aimed at combating specific mutations in the KIT receptor tyrosine kinase, crucial for conditions like systemic mastocytosis and certain gastrointestinal stromal tumors. With a strategic partnership with Plexxikon Inc., Cogent is at the forefront of personalized medicine, transforming the landscape of treatment for patients with complex genetic disorders.

COGT Coverage